SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 15 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,193,000 | -32.7% | 651,615 | +6.3% | 0.00% | -100.0% |
| Q3 2016 | $4,746,000 | +35.2% | 613,121 | -2.2% | 0.00% | 0.0% |
| Q2 2016 | $3,510,000 | +3.2% | 626,872 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $3,401,000 | -38.1% | 632,177 | +0.3% | 0.00% | 0.0% |
| Q4 2015 | $5,491,000 | +7.9% | 630,424 | +3.9% | 0.00% | 0.0% |
| Q3 2015 | $5,090,000 | -55.4% | 606,641 | -6.3% | 0.00% | -50.0% |
| Q2 2015 | $11,409,000 | +124.2% | 647,506 | +47.1% | 0.00% | +100.0% |
| Q1 2015 | $5,088,000 | +35.9% | 440,155 | +18.4% | 0.00% | 0.0% |
| Q4 2014 | $3,744,000 | +186.7% | 371,815 | +28.7% | 0.00% | – |
| Q3 2014 | $1,306,000 | -21.7% | 288,897 | +16.8% | 0.00% | – |
| Q2 2014 | $1,669,000 | -29.6% | 247,287 | +33.6% | 0.00% | – |
| Q1 2014 | $2,372,000 | +129.0% | 185,053 | +44.7% | 0.00% | – |
| Q4 2013 | $1,036,000 | – | 127,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |